Assertio Holdings, Inc. files with the SEC under CIK 0001808665 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F3 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F3 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F3 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Footnote F2 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F3 (shares): [continues from Footnote 2] to receive the Offer Price, less any applicable withholding taxes.
Footnote F4 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F5 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F3 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F3 (shares): Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of… Full note on SEC EDGAR
Footnote F2 (shares): [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes.
Footnote F4 (price): Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was… Full note on SEC EDGAR
Footnote F1 (shares): Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's… Full note on SEC EDGAR
Footnote F1 (shares): Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's… Full note on SEC EDGAR
Footnote F1 (shares): Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's… Full note on SEC EDGAR
Footnote F1 (shares): Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's… Full note on SEC EDGAR
Footnote F1 (shares): Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's… Full note on SEC EDGAR
Footnote F3 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F3 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F3 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Footnote F3 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F1 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F4 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F2 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F5 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F2 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F5 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F2 (shares): Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Footnote F5 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F3 (price): The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Footnote F2 (price): The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on November 10, 2025, at prices ranging from $0.7544 to $0.7668 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer… Full note on SEC EDGAR
Assertio Holdings, Inc. (ASRT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-16. The full record for ASRT runs to 35 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ASRT stock?
No insider purchases of ASRT were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling ASRT stock?
No insider sales of ASRT were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ASRT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ASRT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
William McKee - DirectorOther27,936 sh
Sigurd Kirk - Director
